Clinical Trial Of Rhodiola Rosea L. Extract SHR-5 In The Treatment Of Mild To Moderate Depression
| 効果 | 減少 |
| 試験方法 | 二重盲検法 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 89 |
| 性別 | 男女 |
| 年齢 | 18-29, 30-44, 45-64 |
この研究の注釈：
42 days supplementation of 340-680mg rhodiola SHR-5 extract was able to significantly reduce the symptoms of depression in persons with diagnosed depression, with only partial dose dependence noted.
42 days supplementation of 340-680mg rhodiola SHR-5 extract was able to significantly reduce the symptoms of depression in persons with diagnosed depression, with only partial dose dependence noted.
The degree of improvement ranged from 30-35% (HAMD rating scale) to 50% reduced symptoms (higher dose on BDI).
